Topical CP-690,550 For Chronic Plaque Psoriasis

Summary

Study will test effectiveness of an experimental drug applied once or twice daily to two psoriasis plaques. Requires 1 clinic visit each week for 5 weeks.

Timeline

Start

2008-10-13

Primary completion

2009-07-09

Completion

2009-07-24

Outcome

Missed primary endpoint

paper primary efficacy endpoint) was not significantly different from baseline for any treatment group (P values of 0.28-0.68). PMID 26267721 ↗

Publications

• Ports WC, Feldman SR, Gupta P, Tan H, Johnson TR, Bissonnette R. Randomized Pilot Clinical Trial of Tofacitinib Solution for Plaque Psoriasis: Challenges of the Intra-Subject Study Design. J Drugs Dermatol. 2015 Aug;14(8):777-84.

Drugs

Indications